Lobbying

Colgate - Palmolive CL's latest lobbying report covers Q3 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $230K. Its first report covers Q4 2022; the issues it reports most are Manufacturing and Health Issues.

Colgate - PalmoliveCL

Colgate - Palmolive stock page

Latest quarter
$30K
Q3 2026 · 1 reports
Last 12 months
$230K
Last 4 quarters
vs last quarter
−62.5%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Colgate - Palmolive lobbying by quarter
Colgate - Palmolive lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$60K1
Q3 2023$50K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$20K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$10K1
Q3 2025$10K1
Q4 2025$60K2
Q1 2026$60K2
Q2 2026$80K2
Q3 2026$30K1

By issue

  • Manufacturing$320K · 19 reports
  • Health issues$50K · 3 reports
  • Medical research and clinical labs$50K · 3 reports
  • Taxation$30K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES19 reports
  • SENATE19 reports
  • Food & Drug Administration (FDA)3 reports
  • Health & Human Services, Dept of (HHS)3 reports

Firms it paid

Firm
Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$300K16 quarters
Alpine Group Partners$150K3 quarters

Former officials lobbying for it

Former position
COLIN BRAINARDChief of Staff, Rep. Steve Watkins; Executive Director, Joint Economic Cmte.; Dep. Chief of Staff, Rep. Erik Paulsen; Dep. Chief of Staff, Rep. Lynn Jenkins; LC, Sen. Richard BurrQ2 2026
ERIN MENDELSOHNLD, Rep. Anna Eshoo; Congressional Liaison - FDAQ2 2026
GREG WALDENUS Congressman 1999-2021Q2 2026
HANNAH SCHMIDTProfessional Staff, House Small Business CmteQ2 2026
SHAYNE WOODSSenior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep.Gus BilirakisQ2 2026

Lobbying reports

Filed by
10/01for Q3Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$30K
07/18for Q2Alpine Group Partners$50K
07/01for Q2Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$30K
04/20for Q1Alpine Group Partners$50K
04/01for Q1Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
01/19for Q4 2025Alpine Group Partners$50K
01/02for Q4 2025Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
25/11/04for Q4 2025Alpine Group PartnersUnder $5,000
25/10/01for Q3 2025Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
25/07/08for Q2 2025Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
25/04/07for Q1 2025Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
25/01/21for Q4 2024Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
24/10/17for Q3 2024Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
24/07/09for Q2 2024Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$20K
24/04/10for Q1 2024Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
24/01/23for Q4 2023Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
23/10/18for Q3 2023Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$50K
23/07/17for Q2 2023Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$60K
23/04/13for Q1 2023Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K
23/01/19for Q4 2022Taft Stettinius & Hollister LLP Dba Taft Advisors LLC Fka$10K